Abemaciclib effective as initial therapy for certain women with advanced breast cancer

The addition of abemaciclib (Verzenio) to initial treatment with a nonsteroidal aromatase inhibitor appeared effective for women with hormone receptor-positive, HER-2-negative advanced breast cancer, according to results of the double-blind, phase 3 MONARCH 3 study presented at American Association for Cancer Research Annual Meeting.

Read More HereĀ 


Janelle has blogged 240 posts